share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Ambrose Kristen

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Ambrose Kristen

福泰製藥 | 4：持股變動聲明-高管 Ambrose Kristen
SEC announcement ·  04/03 16:04
Moomoo AI 已提取核心訊息
Kristen Ambrose, SVP & Chief Accounting Officer of Vertex Pharmaceuticals Inc. (VRTX), completed the sale of company shares on two consecutive days. On April 1, 2024, Ambrose sold 225 shares at a price of $418.1 per share, followed by the sale of 240 shares at $419.0 per share on April 2, 2024. The transactions resulted in a total disposal of 465 shares, with the total market value of the disposed shares amounting to $194,632.5. After these transactions, Ambrose's direct holdings in Vertex Pharmaceuticals totaled 7,500 shares. The sales were executed as part of standard financial management, with the first sale being a payment of exercise price or tax liability by delivering or withholding securities, and the second being an open market or private sale.
Kristen Ambrose, SVP & Chief Accounting Officer of Vertex Pharmaceuticals Inc. (VRTX), completed the sale of company shares on two consecutive days. On April 1, 2024, Ambrose sold 225 shares at a price of $418.1 per share, followed by the sale of 240 shares at $419.0 per share on April 2, 2024. The transactions resulted in a total disposal of 465 shares, with the total market value of the disposed shares amounting to $194,632.5. After these transactions, Ambrose's direct holdings in Vertex Pharmaceuticals totaled 7,500 shares. The sales were executed as part of standard financial management, with the first sale being a payment of exercise price or tax liability by delivering or withholding securities, and the second being an open market or private sale.
Vertex Pharmicals Inc.（VRTX）高級副總裁兼首席會計官克里斯汀·安布羅斯連續兩天完成了公司股票的出售。2024年4月1日，安布羅斯以每股418.1美元的價格出售了225股股票，隨後於2024年4月2日以每股419.0美元的價格出售了240股股票。這些交易共出售了465股股份，處置股份的總市值爲194,632.5美元。在這些交易之後，安布羅斯在Vertex Pharmicals的直接持股總額爲7,500股。此次出售是標準財務管理的一部分，第一次出售是通過交付或預扣證券來支付行使價或納稅義務，第二次是公開市場或私募銷售。
Vertex Pharmicals Inc.（VRTX）高級副總裁兼首席會計官克里斯汀·安布羅斯連續兩天完成了公司股票的出售。2024年4月1日，安布羅斯以每股418.1美元的價格出售了225股股票，隨後於2024年4月2日以每股419.0美元的價格出售了240股股票。這些交易共出售了465股股份，處置股份的總市值爲194,632.5美元。在這些交易之後，安布羅斯在Vertex Pharmicals的直接持股總額爲7,500股。此次出售是標準財務管理的一部分，第一次出售是通過交付或預扣證券來支付行使價或納稅義務，第二次是公開市場或私募銷售。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息